Brisbane Alcohol Rehabilitation Centre Launch - Avive Health Best Private Mental Health Hospital in Australia

2024-09-03T18:20:16Z

Brisbane City, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Brisbane City, Queensland -

Avive Clinic Brisbane, a state-of-the-art, 63-bed, private hospital located just outside Brisbane's CBD, is proud to announce the opening of its specialised alcohol rehabilitation program. Situated within a tranquil setting that blends modern design with the restored elegance of the heritage-listed 'Skilmorlie' residence, the clinic offers a comprehensive and compassionate approach to treating alcohol use disorder and related mental health conditions. To learn more visit: https://avivehealth.com.au/locations/brisbane

Led by a team of experienced mental health professionals, Avive Clinic Brisbane provides a safe and supportive environment where individuals struggling with alcohol addiction can start on their journey to recovery. The clinic's multidisciplinary team employs evidence-based therapies and holistic interventions to address the complex physical, psychological, and social aspects of alcohol dependence.

Private Alcohol Rehabilitation Center Brisbane

The Brisbane-based clinical team's mission is to provide individuals with the tools and support they need to break free from the cycle of addiction and reclaim their lives. The team believes that recovery is possible for everyone, and is committed to empowering patients to achieve lasting sobriety.

"Substance use disorders are complex conditions that can significantly impact your health, relationships and daily life," stated an Avive spokesperson. "They are characterised by an uncontrollable use of substances – including alcohol and other drugs – despite the harmful consequences. Although serious, substance use disorders are treatable," they explained.

Alcohol use disorder is a chronic and relapsing condition marked by compulsive alcohol seeking and use, even when faced with its detrimental consequences. This disorder can present itself in a variety of ways, such as struggling to control alcohol intake, a constant preoccupation with alcohol, persistent drinking despite negative outcomes, experiencing withdrawal symptoms when abstaining from alcohol, and developing a tolerance to its effects.

Individuals grappling with substance use disorders, particularly alcohol addiction, may exhibit symptoms like intense cravings, an inability to manage or reduce their drinking, dedicating excessive time to obtaining, using, or recovering from alcohol, neglecting their responsibilities, continuing to drink despite social, physical, or psychological problems, experiencing withdrawal symptoms when not drinking, and needing to consume more alcohol to achieve the desired effect.

The development of alcohol addiction is often attributed to a complex interplay of various factors, such as genetic predispositions, biological vulnerabilities, environmental influences, and psychological conditions. Among the commonly recognized risk factors are a family history of substance use disorders, early exposure to alcohol, experiencing high levels of stress or trauma, the presence of mental health disorders such as depression, anxiety, or PTSD, and social or peer pressure.

Avive Clinic Brisbane has been designed to aid healing and recovery using a personalised, holistic approach. The facility boasts the latest in healthcare design and cutting-edge technology, ensuring patients receive the highest standard of care in a comfortable and therapeutic setting.

Beyond its specialised alcohol rehabilitation program, the clinic extends its expertise to encompass a wide array of mental health conditions, ensuring comprehensive care for its patients. The clinic's services include general adult psychiatry, which addresses a broad spectrum of mental health concerns, as well as targeted treatment for mood disorders, anxiety disorders, and substance use disorders beyond alcohol addiction.

Recognising the profound impact of trauma, the clinic also provides specialised care for both early life (developmental) trauma and adult trauma, with a particular focus on supporting the unique needs of defense personnel, emergency responders, and first responders.

"When planning our new hospital development, the business, in close consultation with our clinicians, took the opportunity to update the treatment experience alongside some key pieces that historically have been missing. In doing so, we can complement each of our patients' individual management plans and interventions to ultimately achieve the best possible patient outcomes," said Dr Matt McDornan, Avive co-founder and Chief Medical Officer.

For those who are struggling or may know someone who is struggling with alcohol addiction, please reach out to Avive Clinic Brisbane for confidential support and information about its personalised treatment programs. For more information visit: https://avivehealth.com.au/conditions-we-treat/substance-use-disorders

About Avive Clinic Brisbane:

https://youtu.be/raGrEPGNjYY?si=7ymUKq3Qjo3sIxNj

Avive Clinic Brisbane is a leading provider of mental health and addiction treatment services in Queensland. Its 63-bed private hospital offers a comprehensive range of programs designed to meet the unique needs of each individual. The medical team is committed to providing compassionate, evidence-based care that empowers patients to achieve lasting recovery and live fulfilling lives.

###

For more information about Avive Health Brisbane, contact the company here:

Avive Health Brisbane
Michelle Lawrence
+61408204337
michellelawrence@avivehealth.com.au
16 Bryden Street
Windsor QLD 4030

CONTACT: Michelle Lawrence

Globe Newswire News

RSS Australian Mining Releases

  • Xanadu’s Near-Term Outlook
    TORONTO , Jan. 21, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) is pleased to provide an update on The Kharmagtai Project and associated discussions about the next steps for the development of the Kharmagtai copper-gold Project with our JV partner, Zijin Mining Group (Zijin). Highlights Xanadu delivered […]
  • Technical Report to Support Kharmagtai Pre-Feasibility Study
    TORONTO, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) announces that the Company has filed an independent National Instrument 43-101 technical report titled National Instrument 43-101 Report, Kharmagtai Copper-Gold Project, South Gobi, Mongolia, effective 10 October 2024. The NI 43-101 Technical Report for the Kharmagtai […]
  • Perseus Mining December Quarter Report Webinar
    Perth, Jan. 09, 2025 (GLOBE NEWSWIRE) -- QUARTERLY REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/ January 9, 2025/ Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its December 2024 Quarterly Results, which are anticipated for release around 8:30am AEDT on Wednesday January 29, 2025. CALL DETAILS Australia: […]
  • Completion of Placement to Zijin Mining
    TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) is pleased to announce that the placement of 26,515,543 fully paid ordinary shares to Jinping (Singapore) Mining Pte Ltd, a wholly owned indirect subsidiary of Zijin Mining Group Co. Ltd (Zijin), at an issue price of A$0.055 per share, […]
  • Confidence Boosting Infill Drilling at Nyanzaga Project
    Perth, Dec. 05, 2024 (GLOBE NEWSWIRE) -- CONFIDENCE BOOSTING INFILL DRILLING AT NYANZAGA PROJECT Perth, Western Australia/December 5, 2024/ Perseus Mining Limited (ASX/TSX: PRU) is pleased to provide an update on ongoing resource definition drilling being conducted at its recently acquired Nyanzaga Gold Project in Tanzania (Nyanzaga or the Project). Designed to increase Perseus’s understanding […]
  • Perseus Mining General Meeting Results
    Perth, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ANNUAL GENERAL MEETING RESULTS Perseus Mining Limited (ASX/TSX: PRU) (Perseus) wishes to release the results of its Annual General Meeting, held on 22 November 2024 at 3pm AWST. All six resolutions were decided on a poll and passed. In accordance with ASX Listing Rule 3.13.2 and Section 251AA […]
  • High Priority Copper Drill Targets Defined at Sant Tolgoi
    TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) is pleased to announce strong surface copper assay results from its Sant Tolgoi Project located in Zavkhan Province of Western Mongolia (Figures 1 and 2). Geological mapping, surface rock-chip sampling and geophysics have confirmed the preference of […]
  • Funding Expanded to $7.5 million & Section 708A(5)(e) Notice
    Not for release to US wire services or distribution in the United States Highlights 4 November Placement expanded to $7.5 million, an increase of $2.0 million on the same termsIncludes 10 million new shares to a sophisticated Australian investorIncludes 26.5 million new shares to Zijin Mining Group Co., Ltd (Zijin) for $1.46 million to maintain […]
  • Xanadu Mines Completes $5.5 Million Placement
    Not for release to US wire services or distribution in the United States TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) advises that on 8 November 2024, it issued 100,000,004 fully paid ordinary shares at a price of $0.055 per share, to a range of sophisticated investors […]
  • Xanadu Mines Announces $5.5 Million Placement
    Not for release to US wire services or distribution in the United States Highlights Firm commitments received for a Placement to raise approximately $5.5 million (before costs).The Placement was well supported by both domestic and international, natural resources-focused institutional investors.The Placement may be expanded to include other potential strategic parties on similar terms, subject to […]

Stay up to date

Get notified about the latest gold mining news as soon as it happens or choose daily or weekly deliveries.
GET Newsletters
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram